Dividend-Rich Dow Jones Stock Pfizer Shows Near-4% Yield; New Buy Point Emerges – Investor’s Business Daily

Investor’s Business Daily
Amid pressure from President Trump, Dividend Leader List member Pfizer (PFE) announced it would defer drug price increases and await the President’s blueprint for drug pricing. The dividend-rich stock is moving up the right side of a potential base and
Dow Slumps on Trump Trade War EscalationTheStreet.com

all 90 news articles

…read more

Source:: Dow Jones News By Google News

Leave a Comment